Filter News
Area of Research
News Topics
- (-) Biomedical (3)
- (-) Environment (3)
- (-) Summit (4)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (1)
- Bioenergy (3)
- Climate Change (1)
- Composites (1)
- Computer Science (4)
- Coronavirus (3)
- Materials Science (6)
- Microscopy (1)
- Nanotechnology (5)
- National Security (1)
- Neutron Science (23)
- Physics (4)
- Quantum Science (3)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
Scientists at ORNL used neutron scattering and supercomputing to better understand how an organic solvent and water work together to break down plant biomass, creating a pathway to significantly improve the production of renewable
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory scientists for Early Career Research Program awards.
An international team of researchers has discovered the hydrogen atoms in a metal hydride material are much more tightly spaced than had been predicted for decades — a feature that could possibly facilitate superconductivity at or near room temperature and pressure.
An international team of scientists, led by the University of Manchester, has developed a metal-organic framework, or MOF, material
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.